Overview
Leah Curtis-Marquez practices practicing medicine in Edmonton, Canada.
Her clinical expertise encompasses Hairy Cell Leukemia (HCL) and Islet Cell Transplantation.
She is actively involved in clinical research, co-authoring 31 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Leah A. Curtis-Marquez
Is Leah A. Curtis-Marquez a top-rated expert for Hairy Cell Leukemia (HCL)?
MediFind is an objective health platform that identifies experts based on real-world data. Leah A. Curtis-Marquez is classified as an Experienced expert for Hairy Cell Leukemia (HCL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Leah A. Curtis-Marquez participate in research or clinical trials?
Yes. Leah A. Curtis-Marquez has published 31 articles and abstracts on conditions like Hairy Cell Leukemia (HCL). You can view a list of Leah A. Curtis-Marquez's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Hairy Cell Leukemia (HCL)Ms. Curtis-Marquez isExperienced. Learn about Hairy Cell Leukemia (HCL).
- Islet Cell TransplantationMs. Curtis-Marquez isExperienced. Learn about Islet Cell Transplantation.